We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ISP:MILIntesa Sanpaolo S.p.A. Analysis

Data as of 2026-06-17 - not real-time

€6.07

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Intesa Sanpaolo delivered a record Q1 2026 net income of €2.8 bn, up 6 % YoY, with an annualized ROE of 21 % and EPS growth of 8 % – reinforcing the robustness of its earnings base. The bank reaffirmed its full‑year net income guidance, supporting confidence in continued profitability. Operating margins remain healthy at roughly 67 %, while the trailing PE of 11.2 is well below the industry average of 17.1, indicating relative cheapness. A dividend yield of 6.27 % and a payout ratio near 66 % provide attractive income, and the forward PE of 9.6 suggests further upside.
Technicals show the 20‑day SMA (5.74) hugging the current price (6.07) with a bullish MACD histogram (+0.04) and an RSI of 65.6, pointing to modest momentum without severe overextension. Volume is increasing and the price sits near the upper resistance at €6.09, while support at €5.42 offers a floor. The Fear & Greed Index reads “Extreme Greed” (92), reflecting strong market sentiment. Volatility over the past 30 days is elevated at 26 %, yet the beta of 0.52 signals low systematic risk. The stock’s upside/downside potential is estimated at +12.6 % / –12.6 %, aligning with the analyst consensus “Buy”. Overall, the combination of solid earnings, undervalued multiples, generous dividend and supportive technicals makes ISP a compelling candidate for investors seeking both income and capital appreciation.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD and rising volume
  • Strong Q1 earnings and reaffirmed guidance
  • Attractive dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • PE multiple well below industry average
  • Consistent profitability and high ROE
  • Support level providing downside protection

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Stable cash generation and strong capital base
  • Long‑term dividend income potential
  • Fundamental undervaluation relative to peers

Key Metrics & Analysis

Financial Health

Revenue Growth6.00%
Profit Margin36.83%
P/E Ratio11.2
ROE14.01%
ROA1.00%
P/B Ratio1.5
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI65.6
Support€5.42
Resistance€6.09
MA 20€5.74
MA 50€5.74
MA 200€5.64
MACDBullish
VolumeIncreasing
Fear & Greed Index92.09

Valuation

Target Price€6.84
Upside/Downside12.58%
GradeUndervalued
TypeBlend
Dividend Yield6.27%

Risk Assessment

Beta0.52
Volatility26.30%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.